Tag: increase

VANCOUVER, British Columbia, July 22, 2025 (GLOBE NEWSWIRE) -- DMG Blockchain Solutions Inc. (TSX-V: DMGI) (OTCQB: DMGGF) (FRANKFURT: 6AX) ("DMG" or the "Company"), a vertically integrated blockchain and data center technology company, today announces that it has engaged a consultant to assess and help implement institutional-grade treasury management within the regulated custody platform operated by its wholly owned subsidiary, Systemic Trust Company ("STC"). This platform would serve both DMG and STC’s clients by offering custody services. DMG is also assessing additional capabilities intended to further enhance treasury value.

ATLANTA, July 22, 2025 (GLOBE NEWSWIRE) -- Mueller Water Products, Inc. (NYSE: MWA) plans to release financial results for its third quarter ended June 30, 2025, after U.S. markets close on Monday, August 4, 2025. On Tuesday, August 5, 2025, at 10:00 a.m. ET, the Company will hold a conference call to discuss earnings and business results. Interested parties are invited to listen via webcast available on the Investor Relations section of the Company’s website www.muellerwaterproducts.com. An archive of the webcast will be available for approximately 90 days following the call.

Largest commercial insurer in the United States releases positive comprehensive coverage for AI-enabled Heartflow Plaque Analysis to support precise diagnosis and management of patients

ATLANTA, July 22, 2025 (GLOBE NEWSWIRE) -- Gray Media, Inc. (“Gray”) (NYSE: GTN) announced today the pricing of its previously announced private offering of $775 million aggregate principal amount of 7.250% senior secured first lien notes due 2033 (the “Notes”). This represents an increase of $75 million over the amount previously announced. The Notes were priced at 100% of par. The offering of the Notes is expected to close on July 25, 2025, subject to customary closing conditions.

CALGARY, Alberta, July 22, 2025 (GLOBE NEWSWIRE) -- Pulse Seismic Inc. (TSX:PSD) (OTCQX:PLSDF) (“Pulse” or the “Company”) is pleased to report its financial and operating results for the three and six months ended June 30, 2025. The unaudited condensed consolidated interim financial statements, accompanying notes and MD&A are being filed on SEDAR+ (www.sedarplus.ca) and will be available on Pulse’s website at www.pulseseismic.com.

Second-quarter highlights

ROCKVILLE, Md., July 22, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the Company expects to report financial and business results for the second quarter of 2025 after the market closes on Tuesday, August 5, 2025.